Allied Healthcare Products (NASDAQ:AHPI) Coverage Initiated by Analysts at

Equities research analysts at began coverage on shares of Allied Healthcare Products (NASDAQ:AHPIGet Rating) in a note issued to investors on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Allied Healthcare Products Stock Performance

Shares of Allied Healthcare Products stock opened at $0.00 on Friday. The stock has a market cap of $14,837.00, a P/E ratio of 0.00 and a beta of -2.17. The stock’s 50 day simple moving average is $0.40 and its 200-day simple moving average is $0.98. Allied Healthcare Products has a 1-year low of $0.00 and a 1-year high of $3.67. The company has a debt-to-equity ratio of 1.52, a current ratio of 2.69 and a quick ratio of 1.27.

Institutional Trading of Allied Healthcare Products

An institutional investor recently raised its position in Allied Healthcare Products stock. Renaissance Technologies LLC increased its position in shares of Allied Healthcare Products, Inc. (NASDAQ:AHPIGet Rating) by 14.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 62,700 shares of the medical equipment provider’s stock after buying an additional 7,900 shares during the quarter. Renaissance Technologies LLC owned about 1.56% of Allied Healthcare Products worth $201,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.15% of the company’s stock.

Allied Healthcare Products Company Profile

(Get Rating)

Allied Healthcare Products, Inc engages in manufacturing respiratory products used in the health care industry in hospitals and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. Its product line includes respiratory care products, medical gas equipment, and emergency medical products.

Read More

Receive News & Ratings for Allied Healthcare Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products and related companies with's FREE daily email newsletter.